Neumann Martin Horst Dieter, Schneck Helen, Decker Yvonne, Schömer Susanne, Franken André, Endris Volker, Pfarr Nicole, Weichert Wilko, Niederacher Dieter, Fehm Tanja, Neubauer Hans
Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine University, Duesseldorf, Germany.
Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Biotechnol Prog. 2017 Jan;33(1):125-132. doi: 10.1002/btpr.2294. Epub 2016 May 17.
Circulating tumor cells (CTC) are rare cells which have left the primary tumor to enter the blood stream. Although only a small CTC subgroup is capable of extravasating, the presence of CTCs is associated with an increased risk of metastasis and a shorter overall survival. Understanding the heterogeneous CTC biology will optimize treatment decisions and will thereby improve patient outcome. For this, robust workflows for detection and isolation of CTCs are urgently required. Here, we present a workflow to characterize CTCs by combining the advantages of both the CellSearch and the CellCelector™ micromanipulation system. CTCs were isolated from CellSearch cartridges using the CellCelector™ system and were deposited into PCR tubes for subsequent molecular analysis (whole genome amplification (WGA) and massive parallel multigene sequencing). By a CellCelector™ screen we reidentified 97% of CellSearch SKBR-3 cells. Furthermore, we isolated 97% of CellSearch -proven patient CTCs using the CellCelector™ system. Therein, we found an almost perfect correlation of R = 0.98 (Spearman's rho correlation, n = 20, p < 0.00001) between the CellSearch CTC count (n = 271) and the CellCelector™ detected CTCs (n = 252). Isolated CTCs were analyzed by WGA and massive parallel multigene sequencing. In total, single nucleotide polymorphisms (SNPs) could be detected in 50 genes in seven CTCs, 12 MCF-7, and 3 T47D cells, respectively. Taken together, CTC quantification via the CellCelector™ system ensures a comprehensive detection of CTCs preidentified by the CellSearch system. Moreover, the isolation of CTCs after CellSearch using the CellCelector™ system guarantees for CTC enrichment without any contaminants enabling subsequent high throughput genomic analyses on single cell level. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:125-132, 2017.
循环肿瘤细胞(CTC)是离开原发性肿瘤进入血流的稀有细胞。尽管只有一小部分CTC亚群能够外渗,但CTC的存在与转移风险增加和总生存期缩短相关。了解异质性CTC生物学特性将优化治疗决策,从而改善患者预后。为此,迫切需要用于检测和分离CTC的强大工作流程。在此,我们展示了一种通过结合CellSearch和CellCelector™显微操作系统的优势来表征CTC的工作流程。使用CellCelector™系统从CellSearch试剂盒中分离出CTC,并将其放入PCR管中用于后续分子分析(全基因组扩增(WGA)和大规模平行多基因测序)。通过CellCelector™筛选,我们重新识别出97%的CellSearch SKBR-3细胞。此外,我们使用CellCelector™系统分离出97%经CellSearch验证的患者CTC。其中,我们发现CellSearch CTC计数(n = 271)与CellCelector™检测到的CTC(n = 252)之间存在几乎完美的相关性,R = 0.98(Spearman秩相关,n = 20,p < 0.00001)。对分离出的CTC进行WGA和大规模平行多基因测序分析。总共分别在7个CTC、12个MCF-7和3个T47D细胞中的50个基因中检测到单核苷酸多态性(SNP)。综上所述,通过CellCelector™系统进行CTC定量可确保全面检测由CellSearch系统预先识别的CTC。此外,在CellSearch之后使用CellCelector™系统分离CTC可保证CTC富集且无任何污染物,从而能够在单细胞水平上进行后续的高通量基因组分析。© 2016美国化学工程师学会生物技术进展,33:125 - 132,2017。